(19)

(11)

EP 4 798 566 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24883149.7 (22) Date of filing: 21.10.2024

(51) International Patent Classification (IPC):  C07D 207/30(2006.01) C07D 207/34(2006.01) C07D 403/12(2006.01) A61P 35/00(2006.01) C07D 403/04(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; C07D 403/12; C07D 401/04; C07D 401/14; C07D 471/04; C07D 405/12; C07D 487/04; C07D 519/00; C07D 231/14; C07D 233/66; C07D 417/12; C07D 413/12; C07D 409/14; C07D 471/08; C07D 277/40 (86) International application number: PCT/US2024/052219 (87) International publication number: WO 2025/090412 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 25.10.2023 US 202363593158 P 24.04.2024 US 202463638238 P (71) Applicant: Kymera Therapeutics, Inc. Watertown, MA 02472 (US)	(72) Inventors: PENNINGTON, Lewis Dale Watertown, Massachusetts 02472 (US) COMER, Eamon Watertown, Massachusetts 02472 (US) FORD, Melissa Watertown, Massachusetts 02472 (US) (74) Representative: Hoffmann Eitle  Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)